Coronary Heart Disease Risk Increased in Hashimoto's Thyroiditis
the Endocrinology Advisor take:
Patients with Hashimoto’s thyroiditis have an increased risk for developing coronary heart disease (CHD) compared to the general population, according to a new study published in the Journal of Clinical Endocrinology & Metabolism.
Previous studies have indicated an increased risk of approximately 20% for CHD in patients with subclinical hyperthyroidism. However, few studies have specifically looked at autoimmune thyroid disease, which can cause cardiovascular disease through chronic inflammation.
The study included 1,165 patients aged at least 20 years who were newly diagnosed with Hashimoto’s thyroiditis from 2000 to 2010 as well as 4,660 patients without the diseases. They were matched by gender, age, baseline comorbidities and index year.
The cumulative incidence of CHD was 2.3% higher in Hashimoto’s thyroiditis patients than in those without the disease. The adjusted HR for developed CHD in the Hashimoto’s thyroiditis group was 1.44, which is higher than figures reported in previous studies.
Even after adjusting for comorbidities, Hashimoto’s thyroiditis still remained a significant risk factor for CHD. Additionally, Hashimoto’s thyroiditis with no thyroxine treatment or treatment for less than 1 year were associated with a higher risk for CHD.
The results provide further evidence that HT is associated with an increased risk for CHD regardless of baseline comorbidities, particularly in women and younger patients. Furthermore, treating Hashimoto’s thyroiditis patients with thyroxine for more than one year can decrease the risk for CHD.
Coronary Heart Disease Risk Increased in Hashimoto’s Thyroiditis
Thyroid disease, such as hyperthyroidism, has been linked to cardiovascular problems, but few studies have looked at autoimmune thyroid disease in particular.
This study sought to show a potential link between Hashimoto's thyroiditis and coronary heart disease (CHD).
Endocrinology Advisor Articles
- Updated Clinical Practice Guidelines on Testosterone Therapy in Men With Hypogonadism
- Semaglutide May Be Useful for Treating Obesity in People Without Diabetes
- Once-Daily Oral Contraceptive for Men Shows Promise
- HbA1c Levels Affect Serum Phospholipids, Inflammation inT2D, CVD
- Reducing Total Daily Insulin Dose in T2D: 3-Meal vs 6-Meal Diet
- American College of Physicians Releases 4 Guidelines for HbA1c Targets in T2D
- Dyslipidemia Drug Indications
- No Difference in Weight Loss Outcomes With Low-Fat vs Low-Carbohydrate Diet
- Damaging Effects of Gastric Bypass Surgery on Bone Mass and Microarchitecture
- Gastric Bypass Surgery Linked to Increased Risk for Nonvertebral Fractures
- Effect of High Androgen Levels on Cardiovascular Risk in Postmenopausal Women
- Fertility in Women Negatively Affected by Asthma Medications
- Glucocorticoid Use in COPD Does Not Increase Fracture Risk
- Drug Copayments Often Cost More Than Prescription Drugs
- Closed-Loop Insulin Delivery Offers Best Outcomes for Pregnant Women With T1D